INS and posterior cortical atrophy: Another study found no protective effects of metformin, insulin, aspirin, or statins against PCa risk [70]. In a Hong Kong-based study comparing PCa risks between SGLT-2is and DPP4-is in T2DM patients, the risk was lower among users of SGLT-2is.